Literature DB >> 2829544

Increased hepatotropism of mutants of MHV, strain JHM, selected with monoclonal antibodies.

J L Leibowitz1, J R DeVries, M Rodriguez.   

Abstract

Mesh:

Substances:

Year:  1987        PMID: 2829544     DOI: 10.1007/978-1-4684-1280-2_41

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  7 in total

1.  Identification of polypeptides encoded in open reading frame 1b of the putative polymerase gene of the murine coronavirus mouse hepatitis virus A59.

Authors:  M R Denison; P W Zoltick; J L Leibowitz; C J Pachuk; S R Weiss
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

2.  Mitochondrial aconitase binds to the 3' untranslated region of the mouse hepatitis virus genome.

Authors:  S K Nanda; J L Leibowitz
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

3.  Immunoglobulin Fc binding activity is associated with the mouse hepatitis virus E2 peplomer protein.

Authors:  E L Oleszak; J L Leibowitz
Journal:  Virology       Date:  1990-05       Impact factor: 3.616

4.  Coronavirus MHV-3-induced apoptosis in macrophages.

Authors:  M Belyavsky; E Belyavskaya; G A Levy; J L Leibowitz
Journal:  Virology       Date:  1998-10-10       Impact factor: 3.616

5.  Microheterogeneity of S-glycoprotein of mouse hepatitis virus temperature-sensitive mutants.

Authors:  E L Oleszak; K Knisley; L S Rodkey; J L Leibowitz
Journal:  J Virol Methods       Date:  1992-07       Impact factor: 2.014

6.  MHV S peplomer protein expressed by a recombinant vaccinia virus vector exhibits IgG Fc-receptor activity.

Authors:  E L Oleszak; S Perlman; J L Leibowitz
Journal:  Virology       Date:  1992-01       Impact factor: 3.616

7.  A functional assay for serum detection of antibodies against SARS-CoV-2 nucleoprotein.

Authors:  Anna Albecka; Dean Clift; Marina Vaysburd; Tyler Rhinesmith; Sarah L Caddy; David M Favara; Helen E Baxendale; Leo C James
Journal:  EMBO J       Date:  2021-07-29       Impact factor: 14.012

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.